Figures & data
Figure 1 Stepwise approach for the treatment of asthma in (A) patients aged 6 years and over and (B) children under 6 years of age, as recommended in the GINA Report.
Abbreviations: FEV1, forced expiratory volume in 1 second; GINA, Global Initiative for Asthma; HDM, house dust mite; ICS, inhaled corticosteroids; IgE, immunoglobulin E; Inc., increase; intermitt, intermittent; LABA, long-acting β2-agonist; LTRA, leukotriene receptor antagonist; med, medium dose; OCS, oral corticosteroids; SABA, short-acting β2-agonist; SLIT, sublingual immunotherapy; theoph, theophylline.
![Figure 1 Stepwise approach for the treatment of asthma in (A) patients aged 6 years and over and (B) children under 6 years of age, as recommended in the GINA Report.](/cms/asset/347b8dcb-0134-41c2-9c63-b042ea6624ea/dtcr_a_161362_f0001_b.jpg)
![Figure 1 Stepwise approach for the treatment of asthma in (A) patients aged 6 years and over and (B) children under 6 years of age, as recommended in the GINA Report.](/cms/asset/b0f9df1e-cdb3-4b18-ab25-1cd21601e149/dtcr_a_161362_f0001a_b.jpg)
Table 1 Key results of Phase III studies with 2.5 and 5 µg tiotropium in children and adolescents with asthma
Table 2 Pharmacokinetics of tiotropium in asthma patients across age groups
Table 3 Asthma clinical trials in adults with LAMAs other than tiotropium
Table 4 Traditional and alternative clinical trial endpoints